NO2891663T3 - - Google Patents

Info

Publication number
NO2891663T3
NO2891663T3 NO13833212A NO13833212A NO2891663T3 NO 2891663 T3 NO2891663 T3 NO 2891663T3 NO 13833212 A NO13833212 A NO 13833212A NO 13833212 A NO13833212 A NO 13833212A NO 2891663 T3 NO2891663 T3 NO 2891663T3
Authority
NO
Norway
Application number
NO13833212A
Other languages
Norwegian (no)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NO2891663T3 publication Critical patent/NO2891663T3/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/572—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 cytotoxic response
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO13833212A 2012-08-31 2013-08-29 NO2891663T3 (cg-RX-API-DMAC7.html)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2012191050 2012-08-31
PCT/JP2013/073084 WO2014034754A1 (ja) 2012-08-31 2013-08-29 Psf1由来ペプチド

Publications (1)

Publication Number Publication Date
NO2891663T3 true NO2891663T3 (cg-RX-API-DMAC7.html) 2018-05-19

Family

ID=50183559

Family Applications (1)

Application Number Title Priority Date Filing Date
NO13833212A NO2891663T3 (cg-RX-API-DMAC7.html) 2012-08-31 2013-08-29

Country Status (9)

Country Link
US (4) US9683016B2 (cg-RX-API-DMAC7.html)
EP (1) EP2891663B8 (cg-RX-API-DMAC7.html)
JP (1) JP5920742B2 (cg-RX-API-DMAC7.html)
DK (1) DK2891663T3 (cg-RX-API-DMAC7.html)
ES (1) ES2662808T3 (cg-RX-API-DMAC7.html)
HU (1) HUE036243T2 (cg-RX-API-DMAC7.html)
NO (1) NO2891663T3 (cg-RX-API-DMAC7.html)
PT (1) PT2891663T (cg-RX-API-DMAC7.html)
WO (1) WO2014034754A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111518216B (zh) * 2019-02-02 2024-02-02 上海细胞治疗集团有限公司 多肽、含有多肽的组合物及其在肿瘤免疫中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4966848A (en) * 1988-02-08 1990-10-30 The General Hospital Corporation Isolation, purification, characterization, cloning and sequencing of N α-acetyltransferase
US5223421A (en) * 1989-10-25 1993-06-29 The General Hospital Corporation Identification of methionine Nα-acetyltransferase
US5595756A (en) * 1993-12-22 1997-01-21 Inex Pharmaceuticals Corporation Liposomal compositions for enhanced retention of bioactive agents
US5688489A (en) * 1995-09-15 1997-11-18 Resolution Pharmaceuticals, Inc. Non-receptor mediated imaging agents
AU2002359281A1 (en) * 2001-10-19 2003-04-28 Dgi Bio Technologies, Inc. Identification of binding partners for specific proteins
WO2003042661A2 (en) 2001-11-13 2003-05-22 Protein Design Labs, Inc. Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer
GB0518877D0 (en) * 2005-09-15 2005-10-26 Medical Res Council Markers and methods
US20100015101A1 (en) * 2006-03-28 2010-01-21 Noriyuki Sato Novel tumor antigen peptides
TWI494319B (zh) 2007-02-21 2015-08-01 Oncotherapy Science Inc 表現腫瘤相關抗原之癌症的胜肽疫苗
US20120237948A1 (en) 2009-09-16 2012-09-20 Shionogi & Co., Ltd. Collagen neoepitope antibody

Also Published As

Publication number Publication date
DK2891663T3 (en) 2018-03-26
US20170173133A1 (en) 2017-06-22
US20180169203A1 (en) 2018-06-21
PT2891663T (pt) 2018-03-20
EP2891663A1 (en) 2015-07-08
US20150218216A1 (en) 2015-08-06
EP2891663B1 (en) 2017-12-20
EP2891663A4 (en) 2016-04-13
US10617750B2 (en) 2020-04-14
ES2662808T3 (es) 2018-04-09
JP5920742B2 (ja) 2016-05-18
EP2891663B8 (en) 2018-04-04
HUE036243T2 (hu) 2018-06-28
US9683016B2 (en) 2017-06-20
US9919039B2 (en) 2018-03-20
JPWO2014034754A1 (ja) 2016-08-08
WO2014034754A1 (ja) 2014-03-06
US20200206330A1 (en) 2020-07-02

Similar Documents

Publication Publication Date Title
BR112014019131A2 (cg-RX-API-DMAC7.html)
BR112014017625A2 (cg-RX-API-DMAC7.html)
BR112014017659A2 (cg-RX-API-DMAC7.html)
BR112014017646A2 (cg-RX-API-DMAC7.html)
BR112014017638A2 (cg-RX-API-DMAC7.html)
AR092201A1 (cg-RX-API-DMAC7.html)
BR112013027865A2 (cg-RX-API-DMAC7.html)
BR112014019371A2 (cg-RX-API-DMAC7.html)
BR112014018938A2 (cg-RX-API-DMAC7.html)
BR112014017634A2 (cg-RX-API-DMAC7.html)
BR112014017644A2 (cg-RX-API-DMAC7.html)
BR112014018143A2 (cg-RX-API-DMAC7.html)
BR112014017647A2 (cg-RX-API-DMAC7.html)
BR112014017652A2 (cg-RX-API-DMAC7.html)
BR112014022793A2 (cg-RX-API-DMAC7.html)
BR112014017630A2 (cg-RX-API-DMAC7.html)
BR112014017627A2 (cg-RX-API-DMAC7.html)
BR112014018436A2 (cg-RX-API-DMAC7.html)
BR112014017631A2 (cg-RX-API-DMAC7.html)
BR112014017641A2 (cg-RX-API-DMAC7.html)
BR112014017921A2 (cg-RX-API-DMAC7.html)
BR112014017671A2 (cg-RX-API-DMAC7.html)
BR112014017636A2 (cg-RX-API-DMAC7.html)
BR112014017667A2 (cg-RX-API-DMAC7.html)
BR112014018090A2 (cg-RX-API-DMAC7.html)